A Product by White Square Chemical, Inc.
NOVUS®— The Most Comfortable Soft Denture Liner in the World
The NOVUS® Advantage – Comfort and Financial
In the United States over 6.5 million new denture arches are fitted annually.
WSQ is focused on promoting NOVUS® as a primary health care tool to address a historic issue with denture discomfort by providing an effective, long lasting cushion between the traditional hard acrylic material from which the majority of dentures are manufactured and human soft tissue and the alveolar bone. In addition, NOVUS® has a proven ability to reduce the incidence of bad breath resulting from bacteria build-up.
Nick Hawkins added “NOVUS® is a win-win both in patient comfort and care and in the economics throughout the system. On average, a dentist may schedule up to three additional, non-revenue producing appointments after delivering the denture to the patient before the patient is comfortable. As a result, dentists across the United States lose approximately $1.8 billion in billable revenue every year. Given the inherent durability of the product, NOVUS® also comes with a five-year warranty, which could also save patients and their insurers a total over $5 billion a year. These figures, allied to the improvements that we have made at NOVUS®, are a clear signal why our customer base of dental laboratories is showing consistent and increasing growth and why some of the largest denture manufacturers in the United States are now showing such interest.”
Background – Chemistry and History
Novus™ is a PNFTM based denture liner. PNFTM is made from dichloropolymer (“DCP”) and is an inorganic polyphosphazene material. The material was manufactured and sold in the 1980’s and 1990’s. PNFTM based products were originally developed and manufactured on a commercial scale by Firestone Corporation with US Department of Defense funding. NOVUS® was developed with a National Institute of Health grant and funding. Hygenic Corporation first commercially introduced the product into the international dental market in the late 1980’s.
Since its formation in 2012, WSQ has been successfully developing a proprietary commercial manufacturing process for the production of DCP and PNFTM. The existing manufacturing process is used today to provide large-scale production at WSQ’s plant in Woburn, MA for the purposes of manufacturing NOVUS®.
WSQ is based in Wilmington DE and is managed by an experienced management team.